https://www.rttnews.com/story.aspx?Id=3432608
Mar 15, 2024 - The major U.S. index futures are currently pointing to a roughly flat open on Friday, with stocks likely to show a lack of direction after ending the previous session mostly lower.
0
rttnews:-8370899467995319644
0
https://www.fool.com/investing/2024/03/17/meet-the-most-innovative-magnificent-seven-stock/?source=iedfolrf0000001
Mar 17, 2024 - Meta Platforms is now a mature business that can directly reward shareholders without compromising its long-term growth.
0
fool:8036201108780217272
0
https://seekingalpha.com/news/4080815-inventiva-phase-2-study-for-mash-drug-meets-primary-endpoint?source=feed_sector_healthcare
Mar 18, 2024 - Inventiva (IVA) reported a Phase 2 study of its drug lanifibranor met its primary efficacy endpoint in the treatment of patients with MASH/NASH and type 2 diabetes. Read more here.
0
sa:5537377861208778410
0
https://www.rttnews.com/3432903/fed-meeting-in-focus-amid-uncertainty-about-interest-rate-outlook.aspx?type=alleco
Mar 18, 2024 - The Federal Reserve's monetary policy meeting will be it the spotlight this week, with the central bank due to announce its latest interest rate decision on Wednesday. The Fed is widely expected to leave interest rates unchanged, but the accompanying statement and economic projections could have a significant impact on the outlook for rates.
0
rttnews:2718695657527199427
0
https://www.rttnews.com/story.aspx?Id=3433190
Mar 19, 2024 - The Federal Reserve's two-day monetary policy meeting gets underway today. The Central bank is widely expected to hold interest rates unchanged, and the focus is going to be on the accompanying statement for clues about when the bank will likely start reducing rates.
0
rttnews:9075842605704231959
0
https://www.zacks.com/stock/news/2243694/bayer-s-bayry-elinzanetant-meets-goals-in-third-phase-iii-study?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2243694
Mar 20, 2024 - Bayer's (BAYRY) pipeline candidate, elinzanetant, achieves primary and secondary goals in late-stage OASIS 3 study supporting submissions for marketing authorization.
zc:8802658197567980243
0
https://www.fool.com/investing/2024/03/24/meet-the-4-worst-performing-dow-stocks-in-2024/?source=iedfolrf0000001
Mar 24, 2024 - Boeing, Intel, Nike, and Apple are all down big this year, for mostly good reasons.
0
fool:-7508753330437671054
0
https://www.fool.com/investing/2024/03/24/meet-the-artificial-intelligence-ai-company-that-n/?source=iedfolrf0000001
Mar 24, 2024 - SoundHound AI's stock has been on fire recently.
0
fool:7858762753575821414
0
https://www.zacks.com/stock/news/2246861/pebblebrook-s-peb-february-operating-results-meet-expectations?cid=CS-ZC-FT-analyst_blog|company_news_-_finance_sector-2246861
Mar 27, 2024 - Pebblebrook's (PEB) operating results for February match its expectations on continued demand recovery in urban markets.
zc:1596483395711168629
0
https://seekingalpha.com/article/4681151-eyes-on-the-us-jobs-report-disney-shareholder-meeting-and-ge-spinoff?source=feed_all_articles
Mar 30, 2024 - Stay informed of key financial events with Seeking Alpha's Stocks to Watch.
0
sa:3160293619443800497
0